1. The company has abundant funds: Tasly Sainaikang Medical Engineering Technology Co., Ltd. was established in April 2022 with a registered capital of 490 million yuan and paid-in capital of 250 million yuan. The company was jointly funded by Sonache Medical Company and Tasly Pharmaceutical Group Co., Ltd. ..
2. Wide product authorization: The transrectal high-intensity focused ultrasound ablation therapeutic instrument produced by the company has been authorized by the regulatory authorities in 62 countries around the world and used in more than 600 authoritative hospitals around the world.